PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 5, 2003Pharmacology69 citations

Amlodipine Increases Endothelial Nitric Oxide by Dual Mechanisms

View Full Paper
RBReinhard BerkelsDTDirk TaubertHBHenning Bartels

Structured PICO

P
Population
Porcine coronary arteries, porcine endothelial cell cultures, EA.hy 926 endothelial cells, and cell-free systems
I
Intervention
Amlodipine (acute addition and 24-hour treatment at 0.1-10 micromol/l; up to 150 micromol/l in cell-free system)
C
Comparator
Control conditions (with and without L-NMMA)
O
Outcome
Endothelial nitric oxide (NO) bioavailability, NO release, and reactive oxygen species formationsurrogate

Amlodipine increases endothelial NO bioavailability via both enhanced NO formation and antioxidative protection, providing a mechanistic basis for its antiatherogenic effects.

Abstract

Several experimental and clinical studies have demonstrated the antiatherogenic profile of the long-acting calcium antagonist amlodipine. Given the pivotal role of endothelial (dys)function during atherogenesis, we investigated the influence of amlodipine on endothelial nitric oxide (NO) bioavailability. Acute addition of amlodipine to segments of porcine coronary arteries resulted in a significant increase in NO release which could be blocked by the NO synthase inhibitor L-NMMA (N-monomethylarginine). This effect was mirrored by a rise in intracellular cGMP levels in porcine endothelial cell cultures. Long-term (24 h) treatment of porcine endothelial cell cultures with amlodipine (0.1-10 micromol/l) significantly enhanced the basal NO formation in a concentration-dependent manner which was abrogated in the presence of L-NMMA (0.1 mmol/l). In EA.hy 926 endothelial cells, amlodipine treatment for 24 h significantly increased the endothelial NO synthase protein expression. To evaluate whether the observed increase in NO was additionally due to an antioxidative protection of NO, we examined the influence of amlodipine in different in vitro models. In a cell-free system, amlodipine quenched superoxide anions (hypoxanthine/xanthine oxidase assay) at high concentrations (150 micromol/l). Addition of artificial membrane preparations (dimyristoylphosphatidylcholine) to mimic a physiological environment significantly enhanced this antioxidative effect. In a more physiological model of hyperglycemia (30 mmol/l, 20 min) induced formation of reactive oxygen species from native endothelial cells of porcine coronary arteries, amlodipine concentration dependently attenuated the reactive oxygen species release (>60%; 10 micromol/l). We conclude, that amlodipine increases the endothelial NO bioavailability, firstly via enhanced NO formation and secondly by prolonging the half-life of NO through antioxidative properties. This may result in an improved endothelial function.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Berkels et al. (2003) studied this question.

synapsesocial.com/papers/6a75944f72c9f0ed5b600072https://doi.org/10.1159/000074241
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Calcium Channel Blockade Enhances Nitric Oxide Synthase Expression by Cultured Endothelial Cells1998 · 88 citations
  2. 2Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidases1999 · 295 citations
  3. 3High D -Glucose–Induced Changes in Endothelial Ca2+/EDRF Signaling are Due to Generation of Superoxide Anions1996 · 137 citations
  4. 4Nifedipine and Bay K 8644 Induce an Increase of [Ca2+] i and Nitric Oxide in Endothelial Cells1999 · 21 citations
  5. 5Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide‐ and kinin‐dependent mechanism2002 · 48 citations